Medoclav (Amoxicillin, Clavulanic Acid)

Amoxicillin interferes with bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, which halts peptidoglycan cross‑linking and leads to cell lysis. Clavulanic acid blocks beta‑lactamase enzymes produced by resistant bacteria, protecting amoxicillin and extending its antibacterial spectrum.

The exact dosage of Medoclav is determined by the prescribing clinician based on the infection type, severity, patient age, weight, and renal function. Healthcare providers follow local guidelines and adjust the regimen to achieve optimal therapeutic effect while minimizing adverse reactions.

Safety data for Medoclav in pregnancy are limited, and the product is classified as a category where risks cannot be ruled out. It should only be used when the potential benefit to the mother outweighs possible risks to the fetus. Breastfeeding mothers should consult a physician, as small amounts may be excreted in milk.

To place an order, visit the Medoclav product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Medoclav adds clavulanic acid to amoxicillin, which inhibits beta‑lactamase enzymes that many bacteria produce to resist amoxicillin alone. This combination broadens the antimicrobial spectrum, making it effective against beta‑lactamase‑producing strains that would otherwise render amoxicillin ineffective.

Store Medoclav at temperatures below 25 °C, in its original packaging, and protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not use the product after the expiry date printed on the label.

Medoclav is taken orally, usually with food or a full glass of water to reduce gastrointestinal irritation. The tablet should be swallowed whole; it should not be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

Serious adverse reactions include anaphylaxis (severe allergic response), Clostridioides difficile‑associated colitis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, significant liver enzyme elevation, and neutropenia. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, severe rash, persistent diarrhea, jaundice, or unexplained fever.

Medoclav is contraindicated in individuals with a known hypersensitivity to amoxicillin, clavulanic acid, other penicillins, or any component of the formulation. Patients with a history of severe allergic reactions to beta‑lactam antibiotics should avoid this medication.